Carl Torbjörn Bäckström
Directeur/Membre du Conseil chez DIAMYD MEDICAL AB
Fortune : 973 $ au 30/04/2024
Postes actifs de Carl Torbjörn Bäckström
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| DIAMYD MEDICAL AB | Directeur/Membre du Conseil | 01/04/2017 | - |
| Independent Dir/Board Member | 01/04/2017 | - | |
Umecrine AB
 Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | Directeur/Membre du Conseil | 01/01/2000 | - |
| Directeur Général | 01/01/2000 | - | |
| Fondateur | 02/06/2010 | - | |
Obstetrics & Gynecology, Inc.
 Obstetrics & Gynecology, Inc. Medical/Nursing ServicesHealth Services Obstetrics & Gynecology, Inc. engages in providing obstetrics and gynecology (ObGyn) and women's health services. The company is headquartered in St. Louis, MO. | Corporate Officer/Principal | 02/06/2010 | - |
| Umea Universitet | Corporate Officer/Principal | 02/06/2010 | - |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Directeur/Membre du Conseil | 01/01/2006 | - |
| Directeur Technique/Scientifique/R&D | 01/01/2006 | - | |
| Fondateur | 01/01/2006 | - | |
| Umeå Neurosteroid Research | Corporate Officer/Principal | - | - |
Historique de carrière de Carl Torbjörn Bäckström
Anciens postes connus de Carl Torbjörn Bäckström
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ASARINA PHARMA AB | Directeur Technique/Scientifique/R&D | 01/10/2018 | - |
| Fondateur | 01/01/2006 | - |
Statistiques
Internationale
| Suède | 7 |
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Founder | 3 |
| Corporate Officer/Principal | 3 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASARINA PHARMA AB | Health Technology |
| DIAMYD MEDICAL AB | Health Technology |
| Entreprise privées | 4 |
|---|---|
Umecrine AB
Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | Health Technology |
Obstetrics & Gynecology, Inc.
Obstetrics & Gynecology, Inc. Medical/Nursing ServicesHealth Services Obstetrics & Gynecology, Inc. engages in providing obstetrics and gynecology (ObGyn) and women's health services. The company is headquartered in St. Louis, MO. | Health Services |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Health Technology |
| Umeå Neurosteroid Research |
- Bourse
- Insiders
- Carl Torbjörn Bäckström
- Expérience
